NCT03917160 is a NA clinical trial of EMS device in Abdominal Wall Restoration, sponsored by InMode MD Ltd..

Who is sponsoring NCT03917160?

NCT03917160 is sponsored by InMode MD Ltd..

What drugs are being tested in NCT03917160?

Interventions in NCT03917160: EMS device.

What condition does NCT03917160 study?

NCT03917160 studies Abdominal Wall Restoration, Diastasis Recti.

Is NCT03917160 still recruiting?

NCT03917160 is currently completed. Last updated 24 November 2021.

Last reviewed 2021-11-24 · How we verify

NCT03917160

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluate the Effect of Abdominal Electrical Muscle Stimulation on Abdominal Wall Restoration in Post - Partum Women

Completed NA Last updated 24 November 2021

What this trial tests

NA trial testing EMS device in Abdominal Wall Restoration in 60 participants. Completed in 1 October 2021.

Timeline

27 March 2019

Primary endpoint
1 October 2021

1 October 2021

Quick facts

Lead sponsor	InMode MD Ltd.
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	60
Start date	27 March 2019
Primary completion	1 October 2021
Estimated completion	1 October 2021
Sites	2 locations across United States

Drugs / interventions tested

EMS device

Conditions studied

Abdominal Wall Restoration — all drugs for Abdominal Wall Restoration →
Diastasis Recti — all drugs for Diastasis Recti →

Sponsor

InMode MD Ltd.

Who can join

Adults 18 to 45, female only, with Abdominal Wall Restoration or Diastasis Recti. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of the study is to evaluate the safety and efficacy of Abdominal EMS (Electrical Muscle Stimulation) on AWR (Abdominal Wall Restoration) in Post - Partum Women

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other InMode MD Ltd. trials

Trials by the same sponsor.

NCT07209397 — Detrusor Nerve Radiofrequency Ablation for Overactive Bladder in Women · NA · recruiting
NCT06283498 — Transvaginal Detrusor Nerve Radiofrequency Ablation for Treatment of Overactive Bladder · NA · enrolling by invitation
NCT06458556 — Transvaginal Radiofrequency Ablation for Overactive Bladder · NA · completed
NCT05830968 — Safety and Efficacy of Radio Frequency for the Treatment of Mild to Severe Inflammatory Acne · NA · recruiting
NCT06283056 — RF Microneedling With Multi-Depth Targeting Per Insertion for The Treatment of Cellulite · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03917160 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by InMode MD Ltd.
Last refreshed: 24 November 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03917160.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing